Lianyungang, China

Haili Lv

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haili Lv. Retrieved from https://idiyas.com/inventor/haili-lv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haili Lv: Innovator in Biopharmaceuticals

Introduction

Haili Lv is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic proteins. His work focuses on addressing critical health challenges through advanced scientific research.

Latest Patents

Haili Lv holds a patent for a groundbreaking invention titled "Bifunctional Protein Against PD-1 and TGF-Beta." This patent represents a significant advancement in the treatment of various diseases, showcasing his commitment to improving healthcare outcomes.

Career Highlights

Haili Lv is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His role within the organization has allowed him to leverage his expertise in biopharmaceutical research and development.

Collaborations

Haili has collaborated with talented colleagues, including Wei Zhao and Yingchun Li, who contribute to the innovative environment at Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Their teamwork fosters a culture of creativity and scientific excellence.

Conclusion

Haili Lv's contributions to the field of biopharmaceuticals, particularly through his patent on a bifunctional protein, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…